Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Andrology|February 23, 2019
AMH and INSL3 in testicular and extragonadal pathophysiology: what do we know?A Sansone, S Kliesch, A M Isidori, et al.
European Journal of Endocrinology|October 3, 1998
Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 casesD Büchter, H M Behre, S Kliesch, et al.
The Journal of Urology|October 23, 1998
Alteration of Sertoli cell differentiation in the presence of carcinoma in situ in human testesS Kliesch, H M Behre, L Hertle, et al.
International Journal of Andrology|November 11, 2010
Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatmentG Pühse, A Secker, S Kemper, et al.
Clinical Endocrinology|September 1, 1999
Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 yearsH M Behre, S von Eckardstein, S Kliesch, et al.
Andrologia|March 1, 1991
The influence of LH and/or FSH on Leydig and Sertoli cell morphology after testicular involution in the Djungarian hamster, Phodopus sungorus, induced by hypophysectomy or short photoperiodsS Kliesch, B Schweifer, P Niklowitz, et al.
Andrology|January 19, 2016
Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adultsJ Rohayem, N Sinthofen, E Nieschlag, et al.
Biology of Reproduction|November 1, 1995
Spontaneous recrudescence of spermatogenesis in the photoinhibited male Djungarian hamster, Phodopus sungorusS Schlatt, M De Geyter, S Kliesch, et al.
Human Reproduction (Oxford, England)|February 10, 1998
Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignanciesS Kliesch, M Bergmann, L Hertle, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1997
High loading and low maintenance doses of a gonadotropin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle-stimulating hormone, and testosterone in normal menH M Behre, S Kliesch, G Pühse, et al.
Pageof 12